ellong SM, Gerlach H, et al. Prevention of
thromboembolic complications in patients with superﬁcial-vein
thrombosis given rivaroxaban or fondaparinux: the open-label,
randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol 2017;4:e105-13.
258. Superﬁcial Thrombophlebit